• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Isracann Biosciences Announces Completion of the Acquisition of Isracann Holdings Inc.

    Nataly Cure
    Oct. 15, 2019 07:12AM PST
    Cannabis Investing News
    CSE:AKE

    Isracann Biosciences Inc. is pleased to announce that it has completed its previously announced acquisition of Isracann Holdings Inc.

    Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE:AKE, XFRA:A49, OTCPINK:ATLEF) (the “Company”) is pleased to announce that it has completed its previously announced acquisition (the “Transaction”) of Isracann Holdings Inc. (formerly, Isracann Biosciences Inc.) (“Isracann”). Terms of the Transaction were set out in a share exchange agreement entered into on March 12, 2019, between the Company, Isracann and the shareholders of Isracann. The Transaction was approved at a special meeting of the shareholders of the Company held on July 5, 2019. The Transaction constitutes a “fundamental change” pursuant to Policy 8 – Fundamental Changes and Change of Business of the Canadian Securities Exchange (the “CSE”) and the Company will carry on the business of Isracann, which is now a wholly owned subsidiary of the Company.

    Name Change and Consolidation

    In connection with the Transaction, the Company consolidated its common shares on the basis of one post-consolidation share for each three pre-consolidation shares (the “Consolidation”) and changed its name to “Isracann Biosciences Inc.”.

    Board of Directors

    The Company is pleased to announce its board of directors following completion of the Transaction is as follows: Darryl Jones, Sean Bromley, Yana Popova, Desmond Balakrishnan and Dr. Irit Arbel.

    In addition, the Company is pleased to announce its executive management as follows:

    • Darryl Jones – Chief Executive Officer and President
    • Yana Popova – Chief Financial Officer and Corporate Secretary
    • Israel Moseson – Chief Operating Officer

    Escrow Release

    Further to a previously announced private placement of subscription receipts of the Company for gross proceeds of $10,110,211 (the “Financing”), the Company is pleased to announce that it has satisfied the escrow release conditions and the net proceeds have been released to the Company. The securities issued pursuant to the Financing are subject to a four month hold period from the escrow release date.

    CSE Listing

    The CSE issued its conditional approval of the Transaction on September 23, 2019. The Company’s post-Consolidation common shares will resume trading on the CSE under the new ticker symbol “IPOT” after the CSE’s conditions for listing are satisfied and the CSE issues its final exchange bulletin confirming the completion of the Transaction.

    Additional information in respect of the Company’s business and the Transaction will be available in the Company’s listing statement which will be filed under Company’s profile on www.sedar.com upon receipt of the CSE’s final approval.

    About Isracann Biosciences Inc.
    Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel’s agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The Company has secured agreements within Israel for medicinal marijuana cultivation. For more information visit: www.isracann.com.

    ON BEHALF OF THE BOARD OF DIRECTORS

    “Darryl Jones”

    Darryl Jones
    Chief Executive Officer and President

    The CSE does not accept responsibility for the adequacy or accuracy of this release.

    All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

    Source

    otcpink:atlefcse:akeisracann biosciences inc.cannabis investingxfra:a49
    The Conversation (0)

    Go Deeper

    AI Powered
    Cannabis Investment: Canadian Cannabis Stocks

    Cannabis Investment: Canadian Cannabis Stocks

    CSE Marijuana Stocks

    CSE Marijuana Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×